The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial

• Published in: Current controlled trials in cardiovascular medicine Vol. 24; no. 1; p. 522
• Main Authors: Hull, Katherine L, Bramham, Kate, Brookes, Cassandra L, Cluley, Victoria, Conefrey, Carmel, Cooper, Nicola J, Eborall, Helen, Fotheringham, James, Graham-Brown, Matthew P M, Gray, Laura J, Mark, Patrick B, Mitra, Sandip, Murphy, Gavin J, Quann, Niamh, Rooshenas, Leila, Warren, Madeleine, Burton, James O
• Format: Journal Article
• Language: English
• Published: England BioMed Central 12.08.2023; BMC
• Subjects: Adolescent; Adult; Clinical trials; Cost analysis; Cost-Benefit Analysis; Cost-effectiveness; End-stage kidney disease; Hemodialysis; Hospitals; Humans; In-centre nocturnal haemodialysis; Intervention; Mixed methods research; Quality of Life; Randomized Controlled Trials as Topic; Renal Dialysis - adverse effects; Renal Dialysis - methods; Renal Replacement Therapy; Science; Study Protocol; United Kingdom > UK; In-centre nocturnal haemodialysis; End-stage kidney disease; Cost-effectiveness; Quality of life

In-centre nocturnal haemodialysis (INHD) offers extended-hours haemodialysis, 6 to 8 h thrice-weekly overnight, with the support of dialysis specialist nurses. There is increasing observational data demonstrating potential benefits of INHD on health-related quality of life (HRQoL). There is a lack o...